There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Is It Depression Relapse or Paxil Withdrawal? How to Tell the Difference

Your patient stopped Paxil. A few days later, they're anxious, emotional, dizzy, exhausted, and convinced their depression is returning.

But is it actually a depressive relapse?

Or are they experiencing antidepressant discontinuation syndrome?

In today's episode of Pearls and Prep, we follow the case of Terry, a patient who recently came off Paxil (paroxetine) and quickly found herself struggling with a wave of uncomfortable symptoms. Through her story, we explore one of the most common and clinically important challenges in psychiatry: distinguishing a true relapse of major depressive disorder from SSRI discontinuation syndrome.

The difference matters.

One diagnosis may suggest the underlying illness is returning. The other may simply reflect the brain adjusting to the sudden absence of a medication it has adapted to over time.

Together we'll break down:

• Antidepressant discontinuation syndrome and why it happens
• Why Paxil (paroxetine) carries one of the highest withdrawal risks among SSRIs
• Brain zaps, dizziness, nausea, flu-like symptoms, and other classic withdrawal signs
• How the timeline helps distinguish withdrawal from depression relapse
• The role of careful symptom assessment and documentation
• Questions clinicians should ask when patients worsen after stopping an antidepressant
• Safe SSRI tapering strategies and common tapering mistakes
• When restarting medication can help clarify the diagnosis
• How to have collaborative conversations about long-term antidepressant treatment

Whether you're a psychiatric nurse practitioner, psychiatry resident, therapist, physician assistant, counselor, or mental health clinician, this episode will help you approach antidepressant discontinuation with greater confidence and avoid one of the most common diagnostic pitfalls in outpatient psychiatry.

Key Takeaways

• Antidepressant discontinuation syndrome can closely resemble a depressive relapse, making careful assessment essential.

• Paxil (paroxetine) is one of the SSRIs most commonly associated with withdrawal symptoms because of its relatively short half-life.

• Physical symptoms such as dizziness, nausea, imbalance, flu-like symptoms, and brain zaps often point toward discontinuation syndrome rather than recurrent depression.

• The timing of symptom onset provides critical diagnostic clues. Withdrawal symptoms typically emerge within days of dose reduction or discontinuation.

• Rapid improvement after restarting Paxil strongly suggests discontinuation syndrome rather than relapse of major depressive disorder.

• A slow, individualized taper is often better tolerated than abrupt discontinuation or aggressive dose reductions.

• Experiencing withdrawal symptoms does not automatically mean a patient requires lifelong antidepressant treatment.

Resources

Join Pearls and Prep for bonus episodes, visual psychiatry pearls, board-style questions, premium case discussions, and exclusive educational content:

patreon.com/pearlsandprep

#Psychiatry #PsychNP #SSRIWithdrawal #PaxilWithdrawal #Paroxetine #AntidepressantDiscontinuationSyndrome #DepressionRelapse #MajorDepressiveDisorder #MentalHealth #PsychiatricNursePractitioner #PsychiatricEducation #BrainZaps #Psychopharmacology #PearlsAndPrep

32

Paxil Withdrawal or Depression Relapse? The Difference Changes Everything

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

Links referenced in this episode:

• patreon.com/pearlsandprep

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy